Michael Healy-Rehn
Michael is a business leader with a long background in biotech, food tech, education, health and wellness sectors. He’s driven to support organisations in integrating emerging technologies into their products and services. At VTT, he is supporting the development of new partnerships with industry, bridging cutting edge research with commercial success.
VTT Technical Research Centre of Finland
Pioneers in Pharma Manufacturing: Using Synthetic Biology to Build New, Innovative Complex Chemical Structures
-
As demand for genetic medicines grows, traditional manufacturing methods are reaching their limits. Leaders in pharma and synbio explore what’s driving innovation in cell and gene therapy (CGT), RNA/DNA therapeutics, and other complex manufacturing spaces, with insights from plasmid DNA production, vaccine manufacturing, and the broader chemicals sector.
Conference Pass
2,495
USD
Keynotes & Firesides
Workshops & Breakouts
1:1 Partnering App
Meals & Receptions
Session Recordings
Until Friday April 18th
Full Rate:
$3,495
